Marketing-authorisation holder · United States
Specgx LLC
29 medicines in 1 country, as authorisation holder and manufacturer.
Group structure
Part of
SpecgxPharmaceutical groupOther companies in the group
Brazil1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 29
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANAFRANIL25mg | 50mg | 75mg · Capsule | Clomipramine | United States | Marketed | 1989 |
| ANEXSIA 5/325325mg; 5mg · Tablet | Paracetamol, Hydrocodone | United States | Marketed | 2000 |
| ANEXSIA 7.5/325325mg; 7.5mg · Tablet | Paracetamol, Hydrocodone | United States | Marketed | 2000 |
| DEXTROAMPHETAMINE SULFATE10mg | 15mg | 5mg · Capsule, extended release | Dexamfetamine | United States | Marketed | 2002 |
| EXALGO12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 32MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 8MG **Federal Register de · Tablet, extended release | Hydromorphone | United States | Not marketed | 2010 |
| FENTANYL-1212.5mcg/hr · Film, extended release | Fentanyl | United States | Marketed | 2005 |
| FENTANYL-3737.5mcg/hr · Film, extended release | Fentanyl | United States | Marketed | 2005 |
| FENTANYL-6262.5mcg/hr · Film, extended release | Fentanyl | United States | Marketed | 2005 |
| HYDROMORPHONE HYDROCHLORIDE2mg | 4mg | 8mg · Tablet | Hydromorphone | United States | Marketed | 1998 |
| LEVORPHANOL TARTRATE1mg | 2mg | 3mg · Tablet | Levorphanol | United States | Marketed | 2000 |
| METHADONE HYDROCHLORIDE10mg/5ml | 5mg/5ml · Solution | Methadone | United States | Marketed | 1981 |
| METHADOSE10mg/ml · Concentrate | Methadone | United States | Marketed | 1973 |
| METHADOSE10mg | 5mg · Tablet | Methadone | United States | Not marketed | 1993 |
| METHADOSE40mg · Tablet, for suspension | Methadone | United States | Marketed | 1993 |
| METHYLIN10mg/5ml | 5mg/5ml · Solution | Methylphenidate | United States | Marketed | 2002 |
| METHYLIN10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, chewable | Methylphenidate | United States | Not marketed | 2003 |
| METHYLIN ER10mg | 20mg · Tablet, extended release | Methylphenidate | United States | Marketed | 2000 |
| METHYLPHENIDATE HYDROCHLORIDE10mg | 15mg | 20mg | 30mg | 40mg | 50mg | 60mg · Capsule, extended release | Methylphenidate | United States | Marketed | 2011 |
| MORPHINE SULFATE100mg | 15mg | 200mg | 30mg | 60mg · Tablet, extended release | Morphine | United States | Marketed | 1998 |
| NALTREXONE HYDROCHLORIDE100mg | 25mg | 50mg · Tablet | Naltrexone | United States | Marketed | 1998 |
| OXYCET325mg; 5mg · Tablet | Paracetamol, Oxycodone | United States | Marketed | 1983 |
| OXYMORPHONE HYDROCHLORIDE10mg | 5mg · Tablet | Oxymorphone | United States | Marketed | 2010 |
| PAMELOR10mg base | 25mg base | 50mg base | 75mg base · Capsule | Nortriptyline | United States | Not marketed | 1977 |
| PAMELOR10mg base/5ml · Solution | Nortriptyline | United States | Not marketed | 1977 |
| PRUCALOPRIDE SUCCINATE1mg base | 2mg base · Tablet | Prucalopride | United States | Marketed | 2024 |